Blood test may end painful bone marrow biopsies for MDS patients

NCT ID NCT07081087

Recruiting now Diagnosis Sponsor: Weizmann Institute of Science Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new blood test called PERIBLOOD-MDS that could diagnose a bone marrow disorder called MDS without needing a painful bone marrow biopsy. Researchers will compare results from the blood test with standard bone marrow exams in 1,500 adults with low blood counts. If the blood test proves accurate, it could make diagnosis much easier for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PERIBLOOD-MDS diagnostic test
What this could lead to: If successful, this could replace painful bone marrow biopsies with a simple blood test for diagnosing MDS, making diagnosis faster and less invasive.
What could go wrong: This is an early-stage observational study, so the test may not prove accurate enough to replace bone marrow evaluation. Results are still being validated against standard methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cytopenia myelodysplastic syndrome pancytopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYTOPENIA MDS

Contacts and locations

Locations

University of California San Diego
RECRUITING

San Diego, California, 92093, United States
University of Miami
RECRUITING

Miami, Florida, 33146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.